# Argenx to Buy Forte Biosciences for $2.2 Billion

> **Open Intelligence Dossier** · First detected: 2026-07-27 15:07 UTC · Category: Business

## Executive Summary
10 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"Argenx to Buy Forte Biosciences for $2.2 Billion" is generating significant coverage in the Business category, with 10 articles from 10 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Yahoo Finance, STAT, GlobeNewswire and Investing.com. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Yahoo Finance | argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class Anti-CD122 Antibody, FB102, to Its Immunology Pipeline | [Source Link](https://news.google.com/rss/articles/CBMingFBVV95cUxOVE1zNmVMTHI2cUtXZndrejRHVFAzQURwSVJteXZHX0E4RVpUQ2RIYXJicHM4aUFwam9LQlVYT01ocDRaR1o3M2ZkUU1JRjNia0FfNUNxWjN3Q3NnMHV5eUdzaFRWOUdJSlRQMktybmxHWnhjcmRhNGdFUHRueUF6bXJtTGRwUnVrN1RXanNJUlNSUEZrX1R5TlUxaGlVdw?oc=5) |
| STAT | Argenx to buy autoimmune-focused Forte Biosciences for $2.2B | [Source Link](https://news.google.com/rss/articles/CBMikwFBVV95cUxOZkJJaVhENXM4NUdLYWVYTWx6RVpOS09yNXlfR0t3NzlXZUo3aVlfZnJjQjBCQmNwZ0ROR2xDVk5LcHQ3VFdLOFVQUjZCMEw5NkdkNEhibmg1UC1NbUN0T1BoRnN4bE5xR3VHVnlJTGRxVmVJWktmUlZuNWx5bDBZZk9POHJXWUNZck9na3N4SXRDTlE?oc=5) |
| GlobeNewswire | argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline | [Source Link](https://news.google.com/rss/articles/CBMilAJBVV95cUxOc3Fqc3hYU1lYWlRpR2l1N3YzM2FsakhySGQ4ek4wcW1ITUt5MEVDUVVuOUVqLXlGckt0ZTBhakgxdkNxUUk2VGxXUm5RWUU1WDJBOVh2X1Fqb2MyMklwVU1sR2EzeGJiT3JEc2NVbDB5d1hGanRZWVUxbXhSNjJRcXdOdDA3MUFfcS1iVTRUNDFEX0FyVk05YXVXbEllSTV4SUo4d0NiTEh2RUFIcGJZUldZdnk5Q1NYWS1QeHpOUEJrTFVFa0FvekRvdk1CN28yaE92ZTBMbkpRSURuRFJ4Q1E2cFlIVVpIYTFYNTVUU2x5b2RlOW9qVHlmSEN0OGh3eHcxcDRMQ3F4UzVWakg3dnZOOXQ?oc=5) |
| Investing.com | TD Cowen downgrades Forte Biosciences stock rating on Argenx deal | [Source Link](https://news.google.com/rss/articles/CBMiwwFBVV95cUxNbV84U0xzMEdnSUg3cUN2aW9pMy1YSUxhb0VoMEtRU0ZLazJxTmJUWEFNR3Q2SmI5Z3RHaUR0WjRVcmgxclpEZllrTzhfU1JTVnM2UUp1V0RjdW1saE5GM3lFN1NISWJzLVZrQ3BQUVprUmtmb1JPSG1CLWhvUWtOLWo1cDIzdFc2U3NqbU54Q0tUeU5VQWxlWEhaNXQya21CTFZnbm5YUlpMbmhhU2JfSE5lTTJTRXR0S2lpSW5zaVBEZUU?oc=5) |
| Axios | Argenx to acquire Forte Biosciences for $2.2B | [Source Link](https://news.google.com/rss/articles/CBMijwFBVV95cUxPSG04NE9yLUpoc1lsWmxfU0tFVjdUQUpUZHlqVE9sZkZjbkNIY01QUk1VcWZfR1FJMWhoRUFJWkZOa3ZZUEh4cWZ5QkhERWRpckp5QjNHaUplek14YTVoVGVSejNsalVLVXExYmtOT01wWjlweFZuVjRjQ1RXSFJwbGg2ZWJiVk9PbW9vSXFMOA?oc=5) |
| Investing.com Canada | TD Cowen downgrades Forte Biosciences stock rating on Argenx deal By Investing.com | [Source Link](https://news.google.com/rss/articles/CBMixAFBVV95cUxQV1VxUnlFMzJrajVPeE9TMi16cGN0aXZ0Z183bGRCbE96YTdGTTVYNHBIUURNaXVGZzZkbFh6UElqMlJOdm5nOUVmeVlrZDFPYjlCQTV2UTZlck9YbnJ6UEFHTzZtVngyaXlaTDV2dWdrV0RjbFQ3WXc0OGl3WGpZdlY5eTVKSFlaQk5abTRmQzdVYjRFRlphMWdmby1fTUZieFhfN3lNaFBIRHhxRXh5RUxKUnFYLWFvRmZrNlkxakd0dzUy?oc=5) |
| FirstWord Pharma | argenx to buy Forte Bio for $2.2B in immunology push | [Source Link](https://news.google.com/rss/articles/CBMiU0FVX3lxTFBmMTJmTEhGeUJPQ0tmR05oRGZkNERzNVdfWmJXMTNfZ25OdU5rclJoSUdiZ2ZzdEVXbkZYaW1ia3hOT0dlTks3SnFVWVpZNFRub0hF?oc=5) |
| Endpoints News | Argenx to pick up autoimmune biotech Forte Biosciences for $2.2B | [Source Link](https://news.google.com/rss/articles/CBMikAFBVV95cUxPbGJQQ2xoZWdsYUFBY0ZfQXI1eEgwY0J5c241bF9ac21KdjBWeV8xem9rQ25pLXJnX2lDQjlzeDhiT0xrYXhXRkJxYmR6QnkwLUloUnBYb3Nzam01V0JRY19PWG9sY2tqaUNBMnhPWTgwR2NFQ3F0NC1aaVB4aG1RYnk4Y0JFWjg2eC12Q3RYcHM?oc=5) |
| Fierce Biotech | Argenx acquires Forte for $2.2B to get hands on phase 2-stage vitiligo drug | [Source Link](https://news.google.com/rss/articles/CBMiowFBVV95cUxPay1YdGdFTkNIN1RzQ1h6YWQ4bWU4NUVsVWxvYUV1RnpNLTZ2c29aSTVxRjV1SXBXYnVHajF5UHBwREVjakFvbVh2dklYSVJxZTFVc2l1dlZUa3VQMkR6Wk03dmZKZ2xiVVFqQnh5NzlTMkdKX21LS3h5ejNmVEoxYXgzYm5IcXhRekxKbFBqSTVha3QwZnVXcTJ3ZkpfSWo3dXBN?oc=5) |
| WSJ | Argenx to Buy Forte Biosciences for $2.2 Billion | [Source Link](https://news.google.com/rss/articles/CBMikwFBVV95cUxQOUdEMW9fWFd2dnh0Ti1rc1NJNUpnMDdWQ3dhT2lBbUR4RDhLVVZiQ1dXVGRiaXMwckg2S240MTNDS0tIc0JxUEZZa3JJeEZXTGFxS0ZPMjFwMjNUUnFCY29HNHdhSHF5dzhULUhQRGgxSC1IVExRay1aTFE0MERQMDQ1VlgxMXk3Z1FXaHhhWDlDa3c?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-07-27/argenx-to-buy-forte-biosciences-for-2-2-billion*